Advisory Board

CEO & Co-Founder, AxialBridge
A clinician-turned-venture partner, Jaspreet leads AxialBridge in advancing global life sciences innovation, drawing on nearly 20 years of experience in clinical research, regulatory strategy, and ecosystem development across North America and the UK.

McCauley Chair of Experimental Ophthalmology, QUB
A world leader in retinal biology and translational science, Alan guides early innovations with deep expertise in diabetic retinopathy, AMD, and clinical implementation.

Founder, FlowCo/RetInnovate | CEO, MediNect Bioservices
Founder of RetInnovate and CEO of MediNect, James champions smarter translational strategy—bridging early innovation with clinical and commercial realities through advanced preclinical modeling and cross-functional insight.

Director, Future Medicines Institute (FMI), Belfast
Driving translational innovation at FMI, Steven brings deep expertise from global regulatory roles at ICON plc to accelerate the journey from discovery to clinical impact.

Clinical Chair of Ophthalmology, QUB | Clinical Lead, NI Eye Screening. A global expert in diabetic eye disease and clinical imaging, Tunde provides insight in whether innovations align with real-world clinical practice and patient-centred care.

CEO, Birota Economics Group | Professor of Health Economics, QUB
A leading expert in health economics and HTA, Chris advises life sciences companies on early-stage value strategy and market access, ensuring innovations are both impactful and economically viable.